Faculty Information - KOBAYASHI Hirohito

Published papers

Academic conference presentation

Research areas

Awards & honors

Education

（Last updated : 2025-05-12 14:53:20）

KOBAYASHI Hirohito
Department School of Medicine, School of Medicine

Position Professor

■ Published papers

1.	Original article	Association between kidney function and outcomes following immune checkpoint inhibitor-based combination therapy in patients with advanced renal cell carcinoma. 2024/04
2.	Original article	Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. 2024/04
3.	Original article	Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy. 2024/02
4.	Original article	Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. 2024/01
5.	Original article	A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection. 2023/12
6.	Original article	Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma. 2023/10
7.	Review article	Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors. 2023/07
8.	Original article	Comparison of outcomes between therapeutic combinations based on immune checkpoint inhibitors or tyrosine kinase inhibitor monotherapy for first-line therapy of patients with advanced renal cell carcinoma outside of clinical trials: A real-world retrospective multi-institutional study. 2023/03
9.	Original article	Impact of body mass index on outcomes in an asian population of advanced renal cell carcinoma and urothelial carcinoma treated with immune checkpoint inhibitors. 2023/02
10.	Original article	Comparison of the impact of immune-related adverse events due to immune checkpoint inhibitor dual combination therapy and immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy in patients with advanced renal cell carcinoma. 2023/01
11.	Original article	Beta-tricalcium phosphate as a possible adjuvant in γδ Tcell-based immune therapy for human disorders 2022/12/20
12.	Original article	Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. 2022/07/08
13.	Original article	Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy of Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria 2022/07/05
14.	Original article	Prognostic impact of trial-eligibility criteria in patients with metastatic renal cell carcinoma. 2022/04
15.	Original article	Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma. 2022/01
16.	Original article	Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma. 2021/12
17.	Original article	Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy. 2021/12
18.	Original article	Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study. 2021/10
19.	Original article	Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. 2021/09
20.	Original article	Prognostic impact of early treatment interruption of nivolumab plus ipilimumab due to immune-related adverse events as first-line therapy for metastatic renal cell carcinoma: A multi-institution retrospective study. 2021/07
21.	Original article	Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma. 2021/06
22.	Original article	Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data. 2021/05
23.	Original article	Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus. 2021/04
24.	Original article	Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma. 2021/04
25.	Original article	Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: a propensity score-matched comparative analysis. 2021/02
26.	Original article	Efficacy of nivolumab versus molecular-targeted therapy as second-line therapy for metastatic renal cell carcinoma: Real-world data from two Japanese institutions. 2021/01
27.	Original article	Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era. 2021/01
28.	Review article	Application of desensitization using IVIG for donor specific antibody positive kidney recipient. current situation and problems. 2020/12/20
29.	Original article	Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney. 2020/06
30.	Original article	The de ritis (aspartate transaminase/alanine transaminase) ratio as a prognosticator in patients with end-stage renal disease-associated renal cell carcinoma. 2020/06
31.	Original article	Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era. 2020/05
32.	Original article	Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution. 2020/05
33.	Original article	Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma. 2020/04
34.	Original article	Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
35.	Original article	Application of gamma-delta T cells obtained by ascites filtration for immunotherapy against malignant refractory ascites 2019/12/02
36.	Original article	Negative effect of immediate sunitinib interruption on survival in patients with metastatic renal cell carcinoma. 2019/11
37.	Original article	Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma. 2019/08
38.	Original article	Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy carried out using the enucleation technique. 2019/07
39.	Original article	Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab. 2019/06
40.	Original article	Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy. 2019/06
41.	Original article	Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma. 2019/04
42.	Original article	Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma. 2019/04
43.	Original article	Prognostic markers for refined stratification of IMDC intermediate-risk metastatic clear cell renal cell carcinoma treated with first-line tyrosine kinase inhibitor therapy. 2019/04
44.	Original article	Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma. 2019/03
45.	Original article	Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study. 2018/10
46.	Original article	Immediate progressive disease in patients with metastatic renal cell carcinoma treated with nivolumab: a multi-institution retrospective study. 2018/10
47.	Original article	Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy. 2018/10
48.	Original article	Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma. 2018/09
49.	Original article	Role of IL-18 on the activation of Vδ2+ T cells – For the development of novel cancer immunotherapy – 2018/07/27
50.	Original article	Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma. 2018/07
51.	Original article	Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy. 2018/07
52.	Original article	Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy. 2018/06
53.	Original article	Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug. 2018/03
54.	Original article	Comparison of Kidney Function in the Early Postoperative Period in Transperitoneal Robot-Assisted Laparoscopic Partial Nephrectomy Between Anterior and Posterior Renal Tumors: A Propensity Score-Matched Study. 2018/02
55.	Original article	Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma. 2017/12
56.	Original article	Comparison of Surgical Outcomes Between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study. 2017/08
57.	Original article	Robot-assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score-matched comparative analysis of surgical outcomes. 2017/07
58.	Original article	Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma. 2017/03
59.	Original article	Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. 2017/02
60.	Original article	Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study. 2017/02
61.	Original article	Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis Patients. 2017/02
62.	Original article	Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer. 2017/02
63.	Original article	A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes. 2016/10
64.	Original article	Sarcopenia and the modified glasgow prognostic score are significant predictors of survival among patients with metastatic renal cell carcinoma who are receiving first-line sunitinib treatment. 2016/10
65.	Original article	Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. 2016/09
66.	Original article	Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis. 2016/07
67.	Original article	Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience with four cases. 2016/07
68.	Original article	Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study. 2016/06
69.	Original article	The magnitude of best tumor shrinkage during second-line targeted therapy affects progressionfree survival but not overall survival in patients with metastatic renal cell carcinoma. 2016/06
70.	Original article	The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma. 2016/03
71.	Original article	Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis. 2016/02
72.	Original article	Early unclamping might reduce the risk of renal artery pseudoaneurysm after robot-assisted laparoscopic partial nephrectomy. 2015/12
73.	Original article	Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population. 2015/10
74.	Original article	Assessment of surgical outcomes of the non-renorrhaphy technique in open partial nephrectomy for ≥T1b renal tumors. 2015/09
75.	Case report	Combination of molecular targeted therapy and surgery for a patient with metastatic renal cell carcinoma with a poor prognosis. 2015/07
76.	Original article	Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy. 2015/04
77.	Review article	γδ T Cell Immunotherapy-A Review. 2015/02
78.	Original article	Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer. 2014/12
79.	Original article	Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal disease. 2014/11
80.	Original article	Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney disease. 2014/06
81.	Original article	Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study. 2014/05
82.	Case report	Cystic local recurrence of renal cell carcinoma after laparoscopic radical nephrectomy in a hemodialysis patient. 2014/03
83.	Original article	Superior Tolerability of Altered Dosing Schedule of Sunitinib with 2-Weeks-on and 1-Week-off in Patients with Metastatic Renal Cell Carcinoma-Comparison to Standard Dosing Schedule of 4-Weeks-on and 2-Weeks-off 2014/03
84.	Original article	Mannitol has no impact on renal function after open partial nephrectomy in solitary kidneys 2014/02
85.	Original article	The influence of RENAL nephrometry score on pre-ruptured pseudoaneurysm formation detected by computed tomography angiography in early postoperative period after minimally invasive partial nephrectomy. 2014/01
86.	Original article	The utility of monitoring serum KL-6 level for predicting the onset of mTOR inhibitors induced interstitial lung disease 2013/07
87.	Original article	Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy 2013/04
88.	Original article	Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience 2013
89.	Original article	Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma 2012/11
90.	Original article	Cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis 2012/09
91.	Original article	Predictors for postoperative renal function after open partial nephrectomy: Including postoperative biomarkers 2012/09
92.	Original article	Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: Bilateral occurrence does not influence cancer-specific survival 2011/12
93.	Original article	Decompressive surgery in combination with preoperative transcatheter arterial embolization: Successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression 2011/10
94.	Original article	Analysis of laparoscopic radical nephrectomy for renal cell carcinoma patients with end stage kidney disease requiring hemodialysis 2011/09
95.	Original article	Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma 2011/08
96.	Original article	Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy 2011/06
97.	Original article	Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center 2011/05
98.	Original article	A new indicator of favorable prognosis in locally advanced renal cell carcinomas: γδ T-cells in peripheral blood. 2011/03
99.	Original article	Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens. 2011/02
100.	Original article	A new indicator of a favorable prognosis in locally advanced renal cell carcinomas: γδ T-cells in peripheral blood 2011
101.	Original article	Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. 2010/12
102.	Original article	Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients 2010/07
103.	Case report	Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma. 2010/02
104.	Original article	Presurgical targeted therapy with tyrosine kinase inhibitors for advanced renal cell carcinoma: clinical results and histopathological therapeutic effects. 2010
105.	Original article	Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival. 2010
106.	Original article	Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience. 2009/03
107.	Original article	Clinical outcome of high-grade non-muscle-invasive bladder cancer: A long-term single center experience 2009
108.	Original article	[A case of bilharziasis diagnosed 10 years later]. 2007/05
109.	Original article	Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. 2007/04
110.	Original article	Synthesis of pyrophosphate-containing compounds that stimulate Vgamma2Vdelta2 T cells: application to cancer immunotherapy. 2007/01
111.	Original article	T-cell mediated induction of allogeneic endothelial cell chemokine expression. 2003/02
112.	Original article	Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts. 2002/08
113.	Original article	Gamma/delta T cells provide innate immunity against renal cell carcinoma. 2001/05
Display 5 items
Display all(113)

■ Academic conference presentation

1.	Evaluation of robotic-assisted versus open radical cystectomy in the elderly. （Speech，General） 2025/04/19
2.	Initial outcomes of prostatic urethral lift for benign prostatic hyperplasia in our hospital. （Speech，General） 2025/04/19
3.	Therapeutic efficacy of Cabozantinib or Axitinib rechallenge for advanced renal cell carcinoma. （Poster notice，General） 2024/04/27
4.	Antibiotic and proton pump inhibitor use and survival of patients receiving immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma. （Poster notice） 2024/04/26
5.	Outcome comparison of IO-IO versus IO-TKI combination therapy for patients with advanced renal cell carcinoma. （Poster notice） 2024/04/26
6.	The retrospective study of upfront cytoreductive nephrectomy for metastatic renal cell carcinoma. （Poster notice，General） 2024/04/25
7.	Comparison of the impacts of immune-related adverse events on the prognosis of patients with advanced renal cell carcinoma between patients treated with IO-IO and IO-TKI combination therapy.. （Poster notice，General） 2023/04/29
8.	Outcome change in patients with advanced renal celcarcinoma outside of clinicalal trials from the tyrosine-kinase inhibitor era to the immune checkpoint inhibitor era. （Poster notice，General） 2023/04/29
9.	Outcome in patients with advanced renal cell carcinoma treated with immunotherapy vs. tyrosine kinase inhibitor based on the status of chronic kidney disease. （Speech，General） 2023/04/20
10.	Effects of first-line immune checkpoint inhibitors in patients with metastatic renal cell carcinoma not meeting trial eligibility criteria. （Poster notice，General） 2022/05/13
11.	Potential survival benefit of deferred nephrectomy in patients treated with nivolumab plus ipilimumab for metastatic renal cell carcinoma. （Poster notice，General） 2022/05/13
12.	Comparison of efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma. （Speech，General） 2020/12/23
13.	Trifecta outcomes of robot-assisted laparoscopic partial nephrectomy compared to conventional partial nephrectomy. （Speech，General） 2020/12/22
14.	The 34th Congress of Japanese Society of Endourology （Speech，General） 2020/11/19
15.	Comparisons of surgical outcomes between transperitoneal and retroperitoneal　approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors: A propensity score-matched comparative analysis. （Speech，General） 2020/07/17
16.	Predictive factors for recurrence after complete metastasectomy in patients with metastaticrenal cell carcinoma in the targeted therapy era. （Speech，General） 2020/07/17
17.	Usefulness of robot-assisted laparoscopic partial nephrectomy using trifecta criteria. （Poster notice，General） 2020/07/17
18.	Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress （Poster notice，General） 2019/12/08
19.	The relationship between metformin and post-operative recurrence of renal cell carcinoma （Poster notice，General） 2019/10/24
20.	Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy performed using the enucleation technique. （Poster notice，General） 2019/05/04
21.	Effect of changes in skeletal muscle mass on oncological outcomes during first-line sunitinib herapy for metastatic renal cell carcinoma. （Poster notice，General） 2019/05/04
22.	Long-term follow-up of renal function and development of chronic kidney disease after partial nephrectomy. （Poster notice，General） 2019/05/04
23.	Presence of peritumoral pseudocapsules detected based on findings from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma. （Poster notice，General） 2019/05/04
24.	Association of immune-related adverse events with prognosis in patients with metastatic renal cell carcinoma treated with nivolumab. （Speech，General） 2019/05/03
25.	Effect of early-period relative dose intensity in first-line sunitinib therapy with a 2-weeks-on and 1-week-off regimen for metastatic renal cell carcinoma. （Poster notice，General） 2018/05/20
26.	Comparison of kidney function in the early postoperative period between a transperitoneal versus retroperitoneal robot-assisted laparoscopic partial nephrectomy for posterior renal tumor : A propensity score-matched study. （Poster notice，General） 2018/05/19
27.	Predictive factors for immediate progression after nivolumab therapy for metastatic renal cell carcinoma. （Speech，General） 2018/04/20
28.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical recurrence in patients with prostate cancer treated with radiotherapy. （Speech，General） 2017/08/19
29.	Clinicopathological characteristics of the patients with acquired-cystic disease-associated renal cell carcinoma according to 2016 WHO classification. （Poster notice，General） 2017/04/21
30.	Usefulness of multiparametric MRI in prognosis for high risk prostate cancer after radiotherapy. （Poster notice，General） 2017/04/21
31.	Impact of surgeon's experience on occurrence of renal artery pseudoaneurysm after robot-assisted laparoscopic partial nephrectomy. （Poster notice，General） 2016/11/11
32.	Comparison of surgical and oncologic outcomes between long-term and short-term dialysis patients undergoing laparoscopic radical nephrectomy for non-metastatic renal cancer. （Poster notice，General） 2016/11/09
33.	Risk factors for asymptomatic renal artery pseudoaneurysm after partial nephrectomy detected by enhanced CT in the early postoperative period. （Poster notice，General） 2016/05/09
34.	Assessment of surgical outcomes of the non-renorrhaphy technique in open partial nephrectomy for =T1B renal tumors. （Poster notice，General） 2016/05/08
35.	Sarcopenia and the modified glasgow prognostic score are significant predictors of patient survival in metastatic renal cell carcinoma patients receiving first-line sunitinib treatment. （Poster notice，General） 2016/05/07
36.	Prostate imaging reporting and data system score before prostate biopsy can predict biochemical failure in prostate cancer patients treated with high-dose-rate brachytherapy. （Poster notice，General） 2016/05/06
37.	Risk factors for asymptomatic renal artery pseudoaneurysm after partial nephrectomy detected by enhanced CT in the early postoperative period. （Poster notice，General） 2016/03/14
38.	Use of mammalian target of rapamycin inhibitors after failure of tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma undergoing hemodialysis: A single-center experience. （Speech，Panelist at Symposium/Workshop (Other)） 2015/10/30
39.	The relationship between the timing of maximum tumor shrinkage during 1st-line targeted therapy and overall survival of patients with metastatic renal cell carcinoma. （Poster notice，General） 2015/05/18
40.	Comparison of survival rates in stage one renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution. （Poster notice，General） 2015/05/17
41.	Template-based lymphadenectomy reduces the risk of regional lymph node recurrence in patients with upper/middle ureteral cancer. （Poster notice，General） 2015/05/15
42.	Limited benefit of targeted therapies on ivc thrombus in renal cell carcinoma. （Poster notice，General） 2014/05/19
43.	Risk factors and management of unruptured renal artery pseudoaneurysms immediately after laparoscopic partial Nephrectomy. （Speech，General） 2014/05/19
44.	High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer. （Poster notice，General） 2014/05/17
45.	Advantages of transperitoneal approach over retroperitoneal approach in laparoscopic radical nephrectomy for renal cancer in patients with dialysis-dependent, end-stage renal disease （Speech，General） 2013/09/09
46.	Impact Of Preoperative C-Reactive Protein On Survival Of Patients On Chronic Hemodialysis Undergoing Nephrectomy For Renal Cell Carcinoma （Speech，General） 2013/08/31
47.	The Clinical Benefit of Targeted Therapies On IVC Thrombus Of Renal Cell Carcinoma （Speech，General） 2013/08/31
48.	Better recovery of kidney function in patients with de novo chronic kidney disease after partial nephrectomy compared with those with pre-existing chronic kidney disease （Poster notice，General） 2013/05/20
49.	Usefulness of temporary inferior vena cava filter in preventing intraoperative pulmonary embolism for patients with renal cell carcinoma extending into inferior vena cava thrombus （Poster notice，General） 2013/05/07
50.	Better kidney functional recovery in patients with de novo CKD after partial nephrectomy compared to those with pre-existing CKD （Speech，General） 2013/05/06
51.	Enhanced CT after partial nephrectomy in early postoperative period to detect asymptomatic renal artery pseudoaneurysm （Poster notice，General） 2013/05/06
52.	Analysis of factors associated with perioperative outcomes in patients with dialysis-dependent end-stage renal disease undergoing laparoscopic radical nephrectomy （Speech，Panelist at Symposium/Workshop (Other)） 2013/02/09
53.	Anatomic complexity quantitated by nephrometry score ssociated with kidney function after partial nephrectomy （Speech，General） 2013/02/08
54.	Impact of RENAL nephrometry Score on Renal Function after Partial Nephrectomy in Solitary Kidneys （Speech，General） 2012/10/01
55.	No Impact of Mannitol on Renal Function after Partial Nephrectomy in Solitary Kidneys （Speech，General） 2012/10/01
56.	Safty of Partial Nephrectomy for Patients on Chronic Anticoagulant Therapy （Speech，General） 2012/10/01
57.	Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to the ERA Including PRE-Cytokine,Cytokine and Targeted Therapy （Speech，General） 2012/08/18
58.	No Impact of Mannitol on Renal Function after Partial Nephrectomy in Solitary Kidneys （Speech，General） 2012/08/18
59.	Significant Negative Impact of Papillary Histological Subtype in Patients with Renal Cell Carcinoma Extending into the Inferior Vena Cava in Comparison to Clear Cell Subtype:Single-Center Experience （Speech，General） 2012/05/22
60.	Favorable Impact of Routine Screening of kidneys on the Overall Survival of Patients with Renal Cell Carcinoma Associated with End Stage Renal Disease under Chronic Dialysis Therapy （Poster notice，General） 2012/05/21
61.	Predictors for Postoperative Renal Function after Partial Nephrectomy-Including Postoperative Biomarkers （Poster notice，General） 2012/05/21
62.	Renal Cell Carcinoma(RCC) in Patients with End-stage Renal Disease: Does it really exhibit favorable prognosis compared to sporadic RCC? （Poster notice，General） 2012/05/20
63.	Incidence of lymph node involvement according to pathological T stage or tumor grade in the urothelial carcinoma of the upper urinary tract （Speech，General） 2011/08/13
64.	Prognosis and characteristics of renal cell carcinoma in hemodialysis patients-Comparison between unilateral and bilateral occurrence （Speech，General） 2011/08/13
65.	The increased utilization of partial nephrectomy for patients with renal cell carcinoma with the normal contralateral kidney-the influence of tumor size on the choice surgical procedure in this expert single center （Speech，General） 2011/05/16
66.	No inpact of tumor location on the residual renal function after nephron-sparing surgery in the patients with renal tumors （Speech，General） 2010/11
67.	Renal cell carcinoma(RCC) in patients with autosomal dominant polycystic kidney diesease(ADPKD) （Speech，General） 2010/11
68.	Greater impact of lymphadenectomy according to the regional node template on the survival of patients with urothelial carcinoma of the upper urinary tract-a comparison between the template and the total number of lymph nodes removed （Speech，General） 2010/05
69.	No impact of tumor location on the residual renal funtion after nephron-sparing surgery in the patients with renal tumors （Speech，General） 2010/05
70.	The impact of the total number of lymph nodes removed and lymph node density on the survival of the patients with transitional cell carcinoma of the upper urinary tract （Poster notice，General） 2009/04
Display 5 items
Display all(70)

■ Research areas

transfusion medicine, urology, immunology

■ Awards & honors

2001

American transplant congress young investigator award

■ Education

1.	1995/04～1999/03	〔Doctoral course〕〔Doctorial Course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,
2.	1987/04～1992/03	Faculty of Medicine, Gunma University, Graduated